CompagOs is bringing better bone health to all by empowering researchers to transform discoveries into clinical applications, while enabling physicians to match patients with the right treatments and support faster recovery. At the core of our mission are our biologically relevant and reproducible Bon3OID™ in vitro bone models, developed using state-of-the-art 3D bioprinting. Leveraging this technology, we are currently focused on developing a blood-based assay to detect bone metastases earlier than existing imaging methods, representing a key step toward advancing bone health. Additionally, we provide comprehensive services to academic researchers and the life sciences industry, utilizing these models for basic research, drug efficacy, and toxicity testing, with a focus on bone biology, rare bone diseases, inflammatory bone disorders, and bone oncology.
Company Details
- Employees
- 5
- Address
- Zürich, Ch
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://compagos.ch
- Keywords
- organotypic bone models, 3D bioprinting, bone biology, bone oncology, rare bone diseases, inflammatory bone diseases, personalized medicine, bone regeneration.
- HQ
- Zürich
Compagos Questions
Compagos's website is https://compagos.ch
Compagos's LinkedIn profile is https://ch.linkedin.com/company/compagos
Compagos has
5 employees.
View email and phone details for 5
employees at Compagos.
Compagos's industry is
Medical and Diagnostic Laboratories
Compagos's top competitors are
Myflow By Mindmetrix Ag,
Alivion,
Craniotech,
Arbrea Labs,
Hemetron,
Imai Medtech,
Hylomorph,
Scanvio Medical,
Aiendoscopic,
Apersys Ag.
Compagos's categories are Medical and Diagnostic Laboratories
